The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework
This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Drugs are released to the market without adequate study, then, after around 70 to 100 patient deaths due to the drug are reported, the drug is pulled from the market. Getting in front of this "problem" would improve the safety of our drug supply.
If this isn't fixed, it won't be long before cognitive specialties, like internal medicine and neurology, start capping their practices and not allowing new Medicare patients.
Here comes a prescription version of generic Zyrtec syrup. At first glance, we wonder how it will compete with over the counter Zyrtec. But wait...there may be a market for this drug
Drug company (Roche) retaliates against an agency that speaks the truth about their chemical - that it's cost is not worth the minimal benefit. This will become more common as time goes on, even here in the bastion of capitalism.
Antipsychotic drugs have been shown to increase morbidity and mortality in demented patients. These agents are used to keep patients calm and easy to manipulate because there is not enough nursing home staff to adequately care for patients mental and physical needs. "Chemical straight-jackets",...
For the right patient, epoietin products can make a world of difference in quality of life. For the wrong patient, the drugs can cause clotting and can be fatal. (I was involved with a patient's care once who died from a PE due to epoietin. She had a hematocrit of 55% when she died.) ...
EMRs are quite expensive, possibly one of the bigger outlays of cash I can think of. EMRs are also a work in evolution, much like operating software: who wants to invest a lot of money on Vista when rumors of a new and better program are out there? The enormous stress of putting one...
Another agent that lowers HBA1C by 0.02% is not a big deal. There are already too many of these products on the market, none of which do much of anything to improve diabetes care.